Posters
ADPKD and Cystic Kidney Disease - 2
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
The C-Terminal Tail of Polycystin-1 (PC1-CTT) Suppresses Cystic Disease in a Pkd2-KO ADPKD Orthologous Mouse Model
Functional Classification of PKD2 Missense Variants Using Saccharomyces cerevisiae
Renal Cyst Decortication for Tuberous Sclerosis Complex Polycystic Kidney Disease
Sex-Specific Association Between Psoas Muscle Index and Kidney Outcomes in Patients with ADPKD
Co-Creation with Community and Patient Partners: A Process for Return of Genomic Results in the Kidney Precision Medicine Project (KPMP)
Identification of Novel Ciliary Microtubule-Binding Proteins That Regulate Primary Cilia Homeostasis
Isolated Proteinuria from Compound Heterozygous CUBN Variants in an Adult Athlete: A Genetics-First Teaching Case
A Stroke of Bad Cysts: A Case of Renal Cysts and Intracerebral Hemorrhage
A Samd9l Missense Variant Drives Autosomal Dominant Cystic Kidney Disease and c-Myc Activation in Mice
CKD, Obesity-Related Complications, and Kidney Care Use in Pediatric Patients with Bardet-Biedl Syndrome: A Multicenter PHIS Study
Association of Metabolites in Dietary Intervention Trials with ADPKD Progression
Unraveling Netrin-1: A Key Mediator of Sex-Based Differences in ADPKD Progression
AGS3 Exhibits Biomolecular Condensate-Like Puncta in Human ADPKD Kidney Epithelium
The Urinary Proteome as a Predictor of Treatment Response to Tolvaptan in ADPKD
Allele-Dependent Mechanisms Drive Phenotypic Heterogeneity and Reveal Therapeutic Modalities in HNF1B-Associated Cystic Kidney Disease
Towards a Better Understanding of NPHP3-Related Ciliopathies
Molecular Architecture of Fibrocystin and Loss-of-Function Variants Implicated in ARPKD
Arginine Vasopressin Receptor 1A (AVPR1A) in Tuberous Sclerosis Complex (TSC) Kidney Cystogenesis and Its Potential as a Therapeutic Target
It Takes More Than Two: MUC1-C, a New Candidate Promoting Kidney Cystogenesis in Tuberous Sclerosis Complex (TSC)
Distinct Renal Cyst Progression Occurs Depending on Depletion Timing in an Ift140 Conditional Knockout Mouse Model
Palmitoylated Pyruvate Kinase M2 Drives Cyst Growth in ADPKD Through Extracellular Vesicle-Mediated Microenvironmental Remodeling
Somatic Variants in a Pig Model of Early ADPKD
Phenotypic Characterization of Embryonic Kidneys in an Ahi1 Knockout Mouse Model of Joubert Syndrome
Comparing Pregnancy-Associated Plasma Protein A Inhibition vs. Tolvaptan in a Mouse Model of ADKPD
Adult Knock-In Zebrafish Model of ADPKD Enables Identification of Genetic Modifiers of Cystic Disease
Expression of the Polycystin-1 C-Terminal Fragment Suppresses Cystic Phenotype in a Mouse Model of Autosomal Dominant Polycystic Kidney Disease
Early Cardiac Remodeling Predicts Kidney Outcomes in Patients with ADPKD
Novel Approaches Reveal Collagen Changes in Early-Stage ADPKD in Zebrafish and Mouse Models
Selective Peroxisome Proliferator-Activated Receptor α Modulator Inhibits Cyst Growth in Two Animal Models of Polycystic Kidney Disease
Development of Novel Animal Models to Study Vasopressin-Independent Pathways in ADPKD
CDK4/6 Inhibitor Abemaciclib Arrests and Reverses Kidney Cystic Progression in Preclinical ADPKD Model
Cost-Benefit Analysis of Tolvaptan for ADPKD in Kuwait: A KDIGO-Guided Markov Model
Longitudinal Changes in miRNAs Involved in Cyst Growth in Polycystic Kidney Disease and Therapeutic Potential of Anti-miRNA Treatment
Caregiver Burden and Decision-Making in ADPKD: Implications for Treatment Choices and Clinical Trial Participation
Defining Regulators of PC2 Ciliary Trafficking Using Endogenous Pkd2-HaloTag Models
Viral Gene Therapy Rescues Cystic and Fibrotic Tubular Phenotypes in ARPKD Organoids
Activation of CFTR Suppresses Calcium-cAMP Signaling and Cyst Growth in ARPKD
Severe Early-Onset Cystic Kidney Disease Associated with a De Novo Heterozygous NEK8 Variant: An ARPKD-Mimicking Phenotype
Quantitative MRI Biomarkers of ARPKD
PKD2 Nontruncating Pathogenic Variant Location Associates with Mayo Imaging Classification (MIC) and Disease Progression in ADPKD
Reduction of Kidney Manifestations with Tolvaptan Through Six Years of the C-MAJOR Registry
Advancing ADPKD Care in the United Arab Emirates: Insights from a Multidisciplinary Expert Forum
First-in-Human Pregnancy-Associated Plasma Protein A Inhibition Achieves Insulin-Like Growth Factor Binding Protein 4 (IGFBP-4) Pathway Modulation in Healthy Volunteers and Patients with ADPKD: Results from Phase 1
Spatial Transcriptomics to Define ADPKD Cyst Morphology and Interrogate Localized Ligand-Receptor Signaling, Anchor Genes, and Enriched Cystic Pathways
In Vitro and In Vivo Investigation of Translation-Blocking Antisense Oligonucleotides in Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin